Sulphated disaccharide and trisaccharide, possibly originating from the N-acetyl-lactosamine and fucosyl-N-acetyl-lactosamine sequences respectively, were detected in the corpus, especially as large oligosaccharides, but were present in the antrum in only very small amounts. The sulphated monosaccharide, however, most probably originating from 6-sulphated N-acetylglucosamine residues at non-reducing termini, was present in all oligosaccharide fractions in both the corpus and antrum.
INTRODUCTION
Glycoprotein in the gastric mucosa is considered to protect the mucosa from acid, pepsin and other destructive reagents. The sulphation of oligosaccharide chains in glycoprotein may be important to this function, since this process imparts a strongly negative charge to glycoprotein molecules, thus influencing rheological properties. The role of sulphated glycoprotein in vivo is still unclear, but it has been found to provide protection from peptic attack by covering the protein substrate (MikuniTakagaki & Hotta, 1979) . Change in the degree of sulphation in human gastric glycoproteins as a result of gastric disorder may be an indication that sulphation performs an important role (Kakei et al., 1984; Goso et al., 1985) . Slomiany & Meyer (1972) have proposed a structure of sulphated oligosaccharide bearing an internal sulphated NN'-diacetylchitobiose sequence in pig gastric glycoprotein. The presence of mono-and bis-sulphated N-acetylglucosamine and galactose residues in rat gastric glycoprotein has been demonstrated with glycoprotein synthesized in vitro (Liau & Horowitz, 1982) . Subsequently Ohara et al. (1983) found evidence for possible regional differences in the biosynthesis of gastric sulphated glycoprotein in the rat. Sulphotransferase has quite recently been shown to be present in a Golgi-rich membrane fraction from rat stomach (Slomiany et al., 1987; Carter et al., 1988; Murty et al., 1988) . Nevertheless additional studies need to be conducted to clarify structural features and biosynthetic mechanisms of sulphated mucus glycoprotein.
In the present study, differences in the sulphation of mucus glycoproteins in the corpus and antrum were investigated by examining 35S-labelled sulphated glycoproteins newly synthesized in vitro.
MATERIALS AND METHODS Incubation of stomach pieces and isolation of mucus glycoproteins
White male Wistar rats (150-170 g) were killed by decapitation and their stomachs rapidly excised and gently washed with ice-cold Dulbecco's phosphate-buffered saline (Bashor, 1979) without Ca2l or Mg2". Incubation of stomach pieces (antrum or corpus, 2 mm x 2 mm, ten pieces/dish) was carried out at 37°C for 5 h with Na235SO4 (carrier-free; New England Nuclear) (150 ,uCi/ dish) in a manner previously described (Ohara et al., 1983) . After being rinsed with ice-cold phosphatebuffered saline, the tissue pieces were boiled for 3 min in 50 mM-Tris/acetate buffer, pH 7.2, containing 2 (v/v) Triton X-100 so as to prevent any degradation by enzymes. The tissue pieces were homogenized with a Physcotron tissue homogenizer (dial setting 6, 30 s twice) and centrifuged at 8000 g for 30 min. Homogenization and centrifugation were repeated for re-extraction. The combined supernatant was applied onto a column (1.5 cm x 45 cm) of Bio-Gel A-1.5 m (100-200 mesh; BioRad Laboratories) previously equilibrated with 50 mMTris/acetate buffer, pH 7.2, containing 2 % Triton X-100. The excluded fraction containing mucus glycoprotein (Azuumi et al., 1980) was collected and subjected to CsCl equilibrium centrifugation for further purification. Centrifugation was performed at 152000 g for 120 h at 10°C with a starting density of 1.45 g/ml. The purified mucus glycoproteins were desalted with Toyopearl HW50S (Tosoh) gel-filtration chromatography by elution with distilled water. Mucus glycoprotein in the culture medium was similarly purified except that no extraction was carried out.
Unlabelled mucus glycoproteins were isolated directly from the corpus and antrum and purified as above, but with hexose as an indicator. Preparation of oligosaccharides from mucus glycoproteins The 35S-labelled mucus glycoproteins (1 x 106--6 x 106 d.p.m.) were incubated with 1 M-NaBH4 in 50 mM-NaOH for 15 h at 45°C to prepare oligosaccharides (Carlson, 1968) . Unlabelled mucus glycoproteins were treated in the same manner but with NaB3H4 (New England Nuclear) (adjusted to 100 mCi/mmol, 0.1 mCi/nmol of oligosaccharides). After acidification with 1 M-acetic acid, the samples were passed through a Dowex 50 X2 (H+ form) column and boric acid was removed by repeated evaporation with methanol. The oligosaccharides were purified by preparative t.l.c. on a cellulose plate with butan-1-ol/ ethanol/water (4:1:1, by vol.) as solvent. The cellulose layer between the origin and elution position of GalNAcH2 was scraped off and extracted with water.
Treatment with hydrazine, HNO2 and borohydride
Treatment with hydrazine and HNO2 was carried out by a previously described procedure (Edge & Spiro, 1984) on samples thoroughly dried in vacuo over P205 overnight. After the addition of 0.5 ml of freshly distilled hydrazine, each sample was heated at 100°C for 15 h under N2 in a sealed tube. The reagent was removed by evaporation in vacuo over a trap of conc. H2SO4, during which toluene was added several times. The deacetylated samples were then treated with 0.5 ml of 0.2 M-NaNO2 in 0.5 M-acetic acid for 2 h at room temperature. After having been passed through a Dowex 50 X4 (H+ form) column, the samples were incubated with 0.1 M-NaBH4 in 50 mM-NaOH for 3 h at room temperature. All products thus produced were recovered by acidification, passage through a Dowex 50 X4 column and removal of boric acid as described above.
Smith periodate oxidation
The radiolabelled saccharides were oxidized with 50 mMsodium metaperiodate in 50 mM-sodium acetate buffer, pH 4.5, for 24 h at 4 'C. The reactions were terminated by the addition of glycerol and, after 1 h at room temperature, the samples were reduced with 50 mMNaBH4 in 0.1 M-sodium borate buffer, pH 10.0, at room temperature for 4 h. After the addition of acetic acid, the samples were applied on to a Darco G60/Celite 535 column (1:1, by wt.) for removal of salts. The oxidized saccharides were recovered in the eluent with 30 0 (v/v) The oligosaccharide samples were applied on to a Toyopearl HWSOS column (1.6 cm x 80 cm) previously equilibrated with 0.1 M-pyridine/acetate buffer, pH 5.0, and eluted with the same solution at a flow rate of 12 ml/h. Fractions (1 ml) were collected and each was assayed for radioactivity. The column was calibrated by eluting Dextran T-500 (Pharmacia), glucose oligomers, GalNAcH2, Gal,3GalNAcH2 prepared from Gal/J3-GalNAc (Bio-Carb) by reduction and GalNAcH2(6-SO4) prepared from 4AGlcA,/3GalNAc(6-SO4) (Seikagaku Kogyo) by Smith periodate degradation.
The glycoprotein samples that had been treated with one of the glycosaminoglycan-degrading enzymes were applied on to a Bio-Gel A-i.Sm column (1.5 cm x 28 cm) equilibrated with 50 mM-Tris/acetate buffer, pH 7.2, containing 4 M-guanidinium chloride, 0.2% Triton X-100 and the proteinase inhibitors specified above. Each fraction eluted from the column was assayed for radioactivity and for hexuronic acid or hexose in the case of keratanase digests. Hexuronic acid was determined after the samples had been precipitated by adding 3 vol. of 95 0 ethanol containing 13 g of potassium acetate/l to remove salts. High-peformance anion-exchange chromatography High-performance anion-exchange chromatography was carried out on a TSK-gel DEAE-SPW column (acetate form; Tosoh) (0.75 cm x 7.5 cm). The samples were applied on to the column and, after being washed with water, were eluted with a linear gradient of 0-2 Mpyridine/acetate buffer, pH 5.0, at a flow rate of 0.5 ml/min for 60 min. Fractions (1 ml) were collected and assayed for radioactivity. The saccharides were resolved by t.l.c. on plastic sheets precoated with cellulose (0.1 mm thickness; E. Merck) in pyridine/ethyl acetate/water/acetic acid (5:5:3: 1, by vol.) (solvent A) or in butan-1 -ol/acetic acid/! M-NH, (3:2: 1, by vol.) (solvent B). A wick of Whatman 3MM paper was clamped to the top of the thin-layer plate and chromatography proceeded for 6 h in solvent A and for 24 h in solvent B. Components were located after the plate had been sprayed with 4-methylnaphthalenebased enhancer by fluorography at -80°C with XAR-5 film (Eastman-Kodak). The following 3H-labelled sulphated saccharides were used as markers: AnManH2(3-SO4) and AnManH2(6-SO4) obtained from glucosamine 3-sulphate and glucosamine 6-sulphate (Sigma Chemical Co.) respectively by HNO2 deamination followed by NaB3H4 reduction as described by Edge & Spiro (1985) , Gal/34AnManH2(6-SO4) and Gal(6-SO4)/I4AnManH2(6-SO4) prepared from bovine cornea keratan sulphate (Seikagaku Kogyo) by treatment with hydrazine and HNO2 followed by NaB3H4 reduction, and AnTalH2(4-SO4) and AnTalH2(6-SO4) prepared from chondroitin sulphate as described by Edge & Spiro (1984) .
Chemical analysis
Hexose was measured by a phenol/H2S04 method (Dubois et al., 1956 ) with galactose as the standard. Protein was determined by the BCA method (Smith et al., 1985) with the Pierce protein assay kit and bovine serum albumin as the standard. Hexuronic acid was measured by the method of Galambos (1967) .
RESULTS

Preparation of 35S-labelled mucus glycoprotein
Radiolabelled macromolecules were extracted with Triton X-100 from tissue pieces of corpus or antrum of rat stomach previously incubated with [35S]sulphate.
They were subsequently obtained from a Bio-Gel A-1.5m column as the excluded fraction, as previously described (Ohara et al., 1983) . 35S-labelled macromolecules were also obtained from the culture medium by Bio-Gel A-1.5m chromatography. These macromolecules were further purified by CsCl centrifugation to remove nucleic acids and proteins (Spee-Brand et al., 1980) . Fig. 1 shows that 35S-labelled macromolecules were recovered from the centrifuge tube as a single peak at a density of about 1.55 g/ml (corpus tissue) or 1.50 g/ml (antrum tissue). Similar elution profiles were also obtained for the 35S-labelled macromolecules in the medium, though the peaks were somewhat broader.
Since unlabelled mucus glycoprotein had a lower density (about 1.50 g/ml) ( Fig. la) , there is the question as to whether 35S-labelled macromolecules contain proteoglycans whose density is higher. For clarification of this point, the 35S-labelled macromolecules in Fig. l Unlabelled macromolecules obtained from the corpus tissue (a) by extraction with 2 % Triton X-100 followed by Bio-Gel A-i .5m chromatography, and 35S-labelled macromolecules from the corpus tissue (b), antral tissue (c), corpus medium (d) and antral medium (e), were subjected to CsCl centrifugation as described in the text. The designated areas were pooled for further study.
activity was detected in the included fraction after keratanase digestion, more than 95 % of the 35S radioactivity was excluded from the column. The same digestion studies on antral 35S-labelled macromolecules showed nearly all 35S radioactivity to be excluded from the column after digestion with each of the above enzymes. It is evident from these results that nearly the 35S-labelled macromolecules in Fig. 1 are not proteoglycans but sulphated glycoproteins. The amount of 35S radioactivity in corpus mucus glycoproteins was about 3 times that in the antral mucus glycoproteins (Table 1) , this being consistent with our previous observations (Ohara et al., 1983 followed by analysis by Bio-Gel A-1.5m chromatography. Each fraction eluted from the column was assayed for radioactivity and hexuronic acid content (indicated by the broken line). Hexuronic acid was measured for the sample precipitated with ethanol to remove guanidinium chloride. The arrow indicates the column volume calibrated by eluting galactose.
respectively, and the remainder from the medium in each case. Subsequent to acid hydrolysis of the 35S-labelled mucus glycoproteins, more than 95 % of the radiolabel was bound to the Dowex 1 column and, after elution, could be almost entirely precipitated as BaSO4 in the presence of a carrier.
Gel filtration of fl-eliminated oligosaccharides from mucus glycoprotein Purified mucus glycoproein was treated with alkaline borohydride and, after being purified by preparative t.l.c., the released oligosaccharides were analysed by Toyopearl HW50S gel-filtration chromatography. The 35S-labelled oligosaccharides released from mucus glycoprotein of corpus tissue showed considerable variation in size (Fig. 3a) . The elution pattern was essentially the same when oligosaccharides from the culture medium were used (Fig. 3c) .
The chemically radiolabelled oligosaccharides obtained from unlabelled mucus glycoprotein by alkalineborotritide treatment differed somewhat from metabolically labelled oligosaccharides. Thus large oligosaccharides were observed in small amounts in 3H-labelled oligosaccharides (Fig. 3a, broken line) . This may indicate that large oligosaccharides are extensively sulphated in corpus mucus glycoproteins.
Though a calibrated column with glucose oligomers was used, 35S-labelled oligosaccharide size could not be determined by gel-filtration chromatography because of the abnormal elution of the sulphated saccharide. Consequently, standard N-acetylgalactosaminitol 6-sulphate was eluted behind N-acetylgalactosaminitol. This abnormality may have been due to interactions between the sulphate residues on the oligosaccharides and resin.
When the 35S-labelled oligosaccharides ofmucus glycoprotein in antrum tissue were subjected to gel-filtration chromatography, the results differed from those for the corpus. Small oligosaccharides were detected as major components but large oligosaccharides were present in only small amounts (Fig. 3b) . In contrast, 3H-labelled oligosaccharides gave elution patterns similar to those of corpus mucus glycoprotein. Also, no significant differences in elution patterns of oligosaccharides were observed for the tissue and medium in the antrum (Fig. 3d) .
35S-labelled oligosaccharide fractions, designated Cl, C2, C3, Al, A2, A3 and A4, were pooled separately and used for further characterization. Because they were available in only limited amounts, 35S-labelled oligosaccharides of mucus glycoproteins in the medium were not used for further characterization. Fig. 4 . T.l.c. of HNO2 deamination products from 35S-labelled oligosaccharides Oligosaccharide fractions separated by gel filtration, Cl, C2 and C3 from Fig. 3(a) and Al, A2, A3 and A4 from Fig. 3(b) , were subjected to deacetylation with hydrazine followed by HNO2 deamination. After reduction, the products were subjected to t.l.c. Migration of 3H-labelled standards is shown by arrows: aM(3S), AnManH2(3-SO4); aM(6S), AnManH2(6-SO4); aT(4S), AnTalH2(4-SO4); aT(6S), AnTalH2(6-SO4); Gal-aM(6S), Gal,f4AnManH2(6-SO4); Gal(6S)-aM(6S), f8-4AnManH2(6-SO4). The oligosaccharides were applied on to a column (1.6 cm x 80 cm) of the gel equilibrated with 0.1 Mpyridine/acetate buffer, pH 5.0. Elution was achieved at a flow rate of 12 ml/h. The designated areas were pooled for further study. Elution of the 35S-labelled oligosaccharide was compared with that of separately chromatographed 3H-labelled oligosaccharides (designated by the broken line) liberated by alkaline-borotritide treatment from unlabelled mucus glycoprotein. The column was calibrated with the following saccharides: 1, Gafl3GalNAcH2; 2, GalNAcH2; 3, GalNAcH2(6-SO4); GI-G16, glucose oligomers prepared by acid hydrolysis of dextran. The excluded volume was determined by eluting Dextran T-500 with the sample.
Position of I35Slsulphate on oligosaccharides
For clarification of sulphate group location on oligosaccharides, the oligosaccharides, after deacetylation by hydrazinolysis, were cleaved by HNO2 deamination and labelled standards were eluted with the sample: 1, GalNAcH2: 2, Gal1,4AnManH2(6-SO4): 3, Gal(6-SO4),84AnManH2(6-SO4). the reduced products were identified by t.l.c. 35S-labelled products from the oligosaccharides gave three major spots, I, II and III, on t.l.c. (Fig. 4) . A time-course study of hydrazinolysis indicated the formation of their maximum yield at approx. 15 h. It was also apparent that none of them consisted of incompletely degradated oligosaccharides, since none of them showed significant decrease with prolonged treatment. The radiolabelled materials remaining near the origin, possibly representing incompletely degradated oligosaccharides or larger sulphated products, were not characterized. Saccharides I and II were identified as AnManH2(6-S04) and Gal,84AnManH2(6-SO4) respectively from their chromatographic migration in solvent systems A (Fig. 4) and B (not shown). In contrast, saccharide III did not co-migrate with any sulphated saccharide standard used in the t.l.c. Further characterization of saccharide III was made for determination of its structure. First, following its purification by preparative t.l.c., saccharide III was subjected to gel filtration on a Toyopearl HW50S column. That this saccharide was eluted at a position between Gal(6-SO4)/J4AnManH2(6-SO4) and GallI4AnManH2(6-SO4) (Fig. 5) indicates that it possibly could be a disaccharide mono-or bis-sulphate or trisaccharide mono-sulphate. Secondly, saccharide III was applied on to an anion-exchange column of DEAE-5PW to study its electrical properties. It was eluted somewhat faster than standard Gal,f4AnManH2(6-SO4) (Fig. 6 Gal, used as control to be sensitive to Smith periodate oxidation and to produce AnManH2(6-SO4). Fig. 8 demonstrates its conversion into Gal,84AnManH2(6-SO4) by digestion of bovine kidney cC-L-fucosidase; C. lampas /-D-galactosidase, however, failed to change its migration on t.l.c., as was also noted for coffee-bean a-D-galactosidase. The same results were observed with t.l.c. with the solvent system B. Saccharide III thus appears to be fucosyl-Gal,84AnManH2(6-S04). For determination of the location of the frucose residue, saccharide III was digested separately with almond emulsin a-L-fucosidases I and II. The former enzyme has been reported to digest olc,3-or oc1,4-linked fucose and the latter to be specific to al,2-linked fucose residues (Ogata-Arakawa et al., 1977) . Fig. 8 (lanes 4, 5 and 6) shows saccharide III to undergo conversion into Galfl4AnManH2(6-SO4) only by fucosidase II. From the experimental results presented above, saccharide III is concluded to be Fuca2Galfl4AnManH2(6-SO4).
Distribution of sulphated saccharides in the oligosaccharides of mucus glycoproteins Fig. 4 and Table 2 show that the radiolabelled AnMan-H2(6-SO4) is present in all fractions of oligosaccharides prepared from both corpus and antral mucus glycoproteins, whereas Gal,84AnManH2(6-SO4) and (Yanagishita et al., 1987) . That limited amounts of 35S-labelled proteoglycans were synthesized under the conditions used is a possibility, however. The differences in the density of 35S-labelled and non-labelled mucus glycoproteins (Fig. 1 ) may be due to differences in the extent of their sulphation (Van Beurden-Lamers et al., 1989) .
Sulphate group locations on oligosaccharides of gastric mucus glycoprotein were determined by methods that included treatment with hydrazine and HNO2. These methods have been shown to be quite useful for characterizing keratan sulphate (Hopwood & Elliott, 1983) and sulphated saccharides of thyroid plasmamembrane glycoprotein (Edge & Spiro, 1984) and thyrogloblin (Spiro & Bhoyroo, 1988) . The detection of Gal,/4AnManH2(6-SO4) indicates that sulphated Nacetyl-lactosamine sequences are present in mucus glycoprotein, and that of Fucoc2Gal, demonstrates that some of the galactose residues in the sulphated N-acetyl-lactosamine sequences undergo a fucosylation. Although the locations of sulphated Nacetyl-lactosamine sequences on oligosaccharides could not be determined by the present methods, it is quite likely that they are located at internal sites, since the sulphated N-acetyl-lactosamine sequence was specifically observed in large oligosaccharides, whose number of Nacetyl-lactosamine sequences should be sufficient for this to be so. The sulphated fucosyl-N-acetyl-lactosamine sequence, however, may be present at non-reducing termini on oligosaccharides. The Fucx2Galfl4GlcNAc sequence carries the blood-group-O antigen and is generally located at non-reducing termini.
The formation of AnManH2(6-SO4) by HNO2 deamination indicates that 6-0-sulphated N-acetylglucosamine residues are possibly at non-reducing termini on oligosaccharide chains. The fact that rat stomach has been found to contain a sulphotransferase that produces sulphated oligosaccharides bearing terminal 6-0-sulphated N-acetylglucosamine (Carter et al., 1988) (Slomiany & Meyer, 1972) . Liau & Horowitz (1982) reported that 6-0-sulphated N-acetylglucosamine is liberated as a major product by mild acid hydrolysis from rat gastric mucus glycoprotein labelled metabolically with [3H]glucosamine and [35S] sulphate. The present data are consistent with this finding, and thus sulphate residues may be concluded to be located at the 6-position of N-acetylglucosamine. They, however, reported that hexosamine bis-sulphate and galactose monosulphate are also present in glycoprotein. The reason for this inconsistency is not apparent at the present, but an HNO2 deamination product containing such sulphated sugars may be too little in amount to permit detection as a clear spot on t.l.c. or may be located near the origin. Sulphated saccharide sequences have been shown in the present study to differ according to site, whether in the corpus or the antrum. Sulphated N-acetyl-lactosamine and sulphated fucosyl-N-acetyl-lactosamine were found to be present as minor sequences in the antrum, and both could be detected in the corpus. Decrease in the degree of sulphation on the N-acetyl-lactosamine sequence in antrum remains to be explained, since large oligosaccharides, which should have N-acetyl-lactosamine sequences, are present in the antrum. Their presence was confirmed by gel-filtration patterns of 3H-labelled oligosaccharides prepared directly from unlabelled mucus glycoprotein from the antral glycoprotein (Fig. 3) . Chromatographic patterns by hexose content and sugar composition analysis of unlabelled oligosaccharides also support their presence (Ohara et al., 1986 . Decrease in sulphation at N-acetyl-lactosamine sequences of oligosaccharides in antral mucus glycoprotein may be explained as resulting from a decrease in the amount of sulphotransferase(s) that produces sulphated lactosamine and/or sulphated fucosyl-N-acetyl-lactosamine sequences. Should this actually be the case, more than one enzyme would be involved in the sulphation of mucus glycoproteins. Enzymes in the antrum would not be capable of transferring sulphate to internal N-acetyl-lactosamine sequences of oligosaccharides. The possibility of the involvement of more than one enzyme is considerable, since two enzymes that transfer sulphate to the 6-position of terminal and internal N-acetylgalactosamine of chondroitin sulphate have been reported (Nakanishi et al., 1981) . Decrease in the sulphotransferase that acts on N-acetyl-lactosamine would also partially explain the decrease in the sulphation of antral mucus glycoprotein (Table 1 ). The lesser extent of sulphation of large oligosaccharides at N-acetyllactosamine sequences in antral mucus glycoprotein may possibly account for differences in the elution profiles of 35S-labelled oligosaccharides in the corpus and antrum.
That the transfer of N-acetylgalactosamine to fucosyl-N-acetyl-lactosamine sequences in non-reducing termini inhibits subsequent sulphation may also adequately serve to explain the lesser sulphation of fucosyl-N-acetyllactosamine sequences in antral glycoprotein oligosaccharides. The presence of N-acetylgalactosamine residues in addition to those located at reducing termini on the oligosaccharides of antral mucus glycoproteins (Ohara et al., 1986) and that of N-acetylgalactosaminyltransferase, a blood-group-A-producing enzyme, in antral microsomal fractions (Iwase et al., 1988) appear consistent with such a possibility.
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